Cytosorbents (CTSO) Reports Prelim Q4 Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Cytosorbents (CTSO) Reports Prelim Q4 Revenue

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

January 3, 2025 7:00 AM EST

Fourth quarter product revenue growth estimated at 22% to 25% year-over-year

Fourth quarter gross margin estimated to improve to approximately 70%

Management will host in-person investor meetings in San Francisco during J.P. Morgan Healthcare Conference week

PRINCETON, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening... More